abstract |
The present invention relates to a composition that comprises a preparation that measures the methylation level of the promoter region of the natriuretic peptide receptor 2 (NPR2) gene, and thus can predict or diagnose hypertension or obesity even when a symptom thereof is not identified visually or from other results, or even at a very early stage. |